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ABSTRACT Understanding the mechanism of saturated fatty acid-induced hepatocyte toxicity may provide insight into cures
for diseases such as obesity-associated cirrhosis. Trehalose, a nonreducing disaccharide shown to protect proteins and cellular
membranes from inactivation or denaturation caused by different stress conditions, also protects hepatocytes from palmitate-
induced toxicity. Our results suggest that trehalose serves as a free radical scavenger and alleviates damage from hydrogen
peroxide secreted by the compromised cells. We also observe that trehalose protects HepG2 cells by interacting with the plasma
membrane to counteract the changes in membrane ﬂuidity induced by palmitate. The experimental results are supported by
molecular dynamics simulations of model cell membranes that closely reﬂect the experimental conditions. Simulations were
performed to understand the speciﬁc interactions between lipid bilayers, palmitate, and trehalose. The simulations results reveal
the early stages of how palmitate induces biophysical changes to the cellular membrane and the role of trehalose in protecting the
membrane structure.
INTRODUCTION
Non-esteriﬁed long-chain free fatty acids (FFAs) are major
sources of cellular energy (1) and essential components in
triglycerides, cholesteryl esters, prostaglandins, and phos-
pholipid syntheses (2,3). There have been numerous reports
on the toxic effects of fatty acids on model cells in vitro.
Andrade et al. showed that both saturated and unsaturated
fatty acids exert toxic effects on melanoma cells through the
loss of membrane integrity or DNA fragmentation (4). Lima
et al. evaluated the toxicity of various fatty acids on Jurkat
(T-lymphocytes) and Raji (B-lymphocytes) cells (5) and found
a positive correlation between the toxicity and the chain
length and number of double bonds in the fatty acids. Their
experiments identiﬁed palmitate among the most toxic of the
fatty acids. FFAs, especially saturated fatty acids, can cause
cell death in many types of cells, including pancreatic b-cell
(6,7), cardiomyocytes (8,9), and hepatocytes (10–12).
Most of the research up until now on the mechanism of cell
death focused on the production of potential or toxic inter-
mediates, such as stearoyl-CoA desaturase 1 (13–15), acids
fromomega oxidation (16,17), reactive oxygen species (ROS),
ceramide (18,19), reduced mitochondrial potential (8), and
reduction of mitochondrial Bcl-2/Bax ratio (11). Recent
studies in our lab suggest that palmitate can cause lipotoxicity
in liver cells through increased production of hydrogen per-
oxide (H2O2) and hydroxyl (*OH) radicals (12). Measure-
ments indicated that the cytotoxicity was not completely
prevented upon treatment with mitochondrial complex in-
hibitors or free radical scavengers. This suggests that mech-
anisms other than ROS production in the mitochondria may
be contributing to the toxicity of palmitate. Therefore, we
investigated the possibility that palmitate-induced toxicity
may be due to hydrophobic effects on the cellular membrane.
Fatty acids are known to have toxic and fusogenic effects on
cells (20,21). The mechanism by which fatty acids exert
cytotoxicity has been identiﬁed as the detergent-effect (22).
According to this hypothesis, ionized fatty acid micelles
solubilize membrane lipids or proteins and disrupt the phys-
ical and functional integrity of cell membranes (20,21).
Identifying chemical agents to prevent or reverse the effect
of fatty acid induced cellular toxicity has been a major focus
of research in the past decades. Studies have suggested that
saturated and unsaturated fatty acids have different effects on
toxicity. For example, there has been evidence indicating that
dietary oleic acid can protect endothelial cells against hy-
drogen peroxide-induced oxidative stress and reduce the
susceptibility of LDLs to oxidative modiﬁcations (23–25).
Similarly, we found that oleic acid does not induce the same
level of cytotoxicity as palmitic acid in HepG2 cells at similar
concentrations (12) and the addition of oleic acid reduces the
cytotoxicity induced by palmitate (26). In another related
study, Kinter et al. investigated the protective role of unsat-
urated FFA in oxygen-induced toxicity of hamster ﬁbroblasts
and found that monounsaturated FFA increased cell survival
as compared to saturated and polyunsaturated FFAs (27).
Furthermore, it has been shown that unsaturated FFAs res-
cued palmitate-induced apoptosis by converting palmitate
into triglycerides (13). Recently, Natali et al. investigated the
effects of various types of FFAs in glial cells and found that
oleic acid was a potent inhibitor of fatty acid and cholesterol
synthesis (28). In recent years, it has been established ex-
perimentally that trehalose has a stabilizing effect on bio-
logical membranes (29) by protecting cells from dehydration,
heat, and cold (30–32). Moreover, evidence is mounting
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suggesting that trehalose acts as an antioxidant, possibly
serves as a free radical scavenger (33–35), and inhibits the
peroxidation of unsaturated fatty acids by heat or oxygen
radicals (35,36). In addition, trehalose has been found to
protect yeast cells and cellular proteins from damage by
oxygen radicals during oxidative stress (37). In light of the
role trehalose plays in the stabilization of cells, we investi-
gated whether trehalose is protective in the presence of pal-
mitate, and if so, we aimed at understanding how trehalose
protects against palmitate-induced toxicity.
Therefore, to gain insight into how trehalose interacts with
liver cells (human hepatocellular carcinoma cell line, HepG2
cells) in the presence of palmitate, we performed a series of
experimental and computational measurements. The experi-
mental measurements focused on determining the inﬂuence
of palmitate and trehalose on the fate of HepG2 cells, and the
computational part aimed at interpreting and understanding
the experimental results, shedding light into the role of pal-
mitate and trehalose in the toxicity of HepG2 cells. Insight
into these mechanisms will add to our understanding of pro-
cesses (i.e., metabolic, signaling, and biophysical) that are
altered by palmitate. We found that palmitate decreased the
cellular membrane ﬂuidity of HepG2 cells. The addition of
trehalose to palmitate cultures prevented this lowering in
membrane ﬂuidity. Thus, we found that trehalose protects
also against palmitate-induced toxicity in liver cells. This
study represents the ﬁrst attempt to obtain a comprehensive
understanding of the biochemical and biophysical processes
leading to and resulting from the toxicity of palmitate on cells.
EXPERIMENTAL MATERIALS AND METHODS
Cell culture
Human hepatocellular carcinoma cell line, HepG2 (American Type Culture
Collection, Manassas, VA), was cultured in Dulbecco’s modiﬁed Eagle’s
medium (DMEM, Invitrogen, Carlsbad, CA) containing 10% fetal bovine
serum (American Type Culture Collection) and 2% penicillin-streptomycin
(Invitrogen). They were seeded in six-well plates and incubated at 37C in
humidiﬁed atmosphere containing 10% CO2. After cells reached conﬂuence,
the media were replacedwith 2ml control medium (4% fatty-acid free bovine
serum albumin, or BSA) or palmitate (0.7 mM with 4% BSA) and changed
every 24 h. The BSA level used was close to physiological conditions (38). A
quantity of 0.7 mM FFAs was employed in this study because the plasma
FFA levels in the obese and type 2 diabetic patients have been reported to be
approximately this level (39–42). Experiments were conducted after 48 h of
treatment. To determine the optimal amount of trehalose to add, we performed
a dose-response in HepG2 cells with trehalose ranging from 0 to 0.2 mM.
Cytotoxicity assay
Cell viability was assessed by lactate dehydrogenase (LDH) leakage through
themembrane into the medium. The cell culture supernatant from control and
palmitate-treated cultures were tested after 48 h of incubation for the pres-
ence of LDH (LDHmedium) using an LDH assay kit (Roche Applied Science,
Indianapolis, IN). Cells were washed with phosphate-buffered saline (PBS)
and lysed with 1% triton-X 100 for 12 h at 37C. The cell lysate was then
centrifuged at 5000 g for 10 min and tested for LDH activity (LDHtriton). The
LDH released was normalized to the total LDH, given by
%LDHrelease ¼ LDHmedium
LDHmedium1 LDHtriton
3 100: (1)
Membrane ﬂuidity
Two different stearic-acid derivatives were used to detect changes in the
membrane ﬂuidity, 5-n-doxylstearic acid (5-n-SASL) and 16-n-doxylstearic
acid (16-n-SASL) (Invitrogen, Carlsbad, CA). The 5-n-SASL probe moni-
tors the portion of the membrane closest to the lipid headgroups, while the
16-n-SASL reﬂects changes in the middle/end of the lipid hydrocarbon
chains (43).
A stock solution of the spin labeled stearic acids at 103 M was prepared
in dimethyl-sulfoxide and the aliquots stored at 20C. Immediately before
use, the stock solution was thawed and diluted 50 times with PBS. Prelim-
inary experiments were conducted to conﬁrm that the spin-label solution did
not affect the cell viability. Cell suspensions collected after Trypsin-EDTA
(GIBCO, Billings, MT) exposure were centrifuged and the pellets were re-
suspended in spin label solution and kept on ice. The labeled cell suspensions
were then transferred to a ﬂat cell and placed in the cavity of the electron
paramagnetic resonance (EPR) spectrometer (model No. ESP-300E X-band;
Bruker AXS, Madison, WI). The microwave power was set at 15.8 mW,
the modulation frequency at 100 kHz, and the modulation amplitude at
2.53 G. For indexes of membrane ﬂuidity, we evaluated the values of the
outer and inner hyperﬁne splitting (2T? and 2Tk in Gauss, respectively) in the
EPR spectra for 5-n-SASL. The order parameter was calculated from 2T?
and 2Tk by
S ¼ Tk  ðT?1CÞ
Tk1 ð2T?1CÞ3 1:66; (2)
where C¼ 1.4 – 0.053(Tk – T?). In the EPR spectra for 16-n-SASL, we used
the peak height ratio (ho/h – 1) for an index of the membrane ﬂuidity (44,45),
where ho and h – 1 are the heights of the central and high-ﬁeld peaks,
respectively. The greater the values of the order parameter and peak height
ratio, the lower the freedom of motion of the spin labels in the membrane
bilayers, indicating lower membrane ﬂuidity (43).
Liposome preparation and DSC measurement
To correlate the ﬂuidity measurements to our computational studies, a sim-
pler model cell membrane also was used. Liposomes (multilamellar vesicles)
were prepared by the thin ﬁlm method according to the protocol from Avanti
Polar Lipids. The lipid 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC,
Avanti Polar Lipids, Alabaster, AL) and palmitic acid (Sigma-Aldrich, St.
Louis, MO), obtained in chloroform stock solutions, were mixed in appro-
priate amounts in a glass tube. After vortexing, the solvent was dried under
nitrogen. This formed a thin lipid ﬁlm on the inside wall of the glass tube. The
ﬁlm was dried in a freeze-dryer to ensure complete evaporation of chloro-
form. Deionized water was added into the tube before it was placed in a bath
sonicator for 10 min. Differential scanning calorimetry (DSC) analysis were
performed on the liposomes samples at a scan rate of 1C/min. Samples
containing 20 mg/ml of lipid and 10 mL of liposome suspensions were used.
DOPC was used in these experiments because its phase transition tempera-
ture (;19C) allowed us to obtain clean and clear DSC scans, whereas
POPC (one of the lipids used in the simulations studies) has a phase transition
temperature near the normal melting point of water (2C for POPC), which
causes severe interference in obtaining reliable data.
SIMULATION DETAILS
To gain insight into how palmitate induces cytotoxicity, we
used MD simulations to investigate the role palmitate and
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trehalose play in the structure and integrity of lipid bilayers
(model biological membranes). The lipid bilayers used here
are equimolar 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-
choline/1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethano-
lamine (POPC/POPE) bilayers with a total of 288 lipid
molecules evenly distributed in each leaﬂet (System 1 in
Table 1). This mixed bilayer was chosen for these studies
because it represents the main phospholipid constituents of
HepG2 cells (46). Note that other major lipid constituents
(e.g., cholesterol) were not included in these simpliﬁedmodel
bilayers. Combinations of palmitate and trehalose were in-
troduced into the lipid bilayer systems. The structure of the
molecules considered is shown in Fig. S1 in the Supple-
mentary Material.
To mimic the exposure of palmitate to cells with and
without trehalose, a palmitate molecule was inserted into the
middle of the aqueous phase of previously equilibrated lipid
bilayers (System 3 in Table 1). For the systems with treha-
lose, a concentration of ;5 wt % trehalose was used in the
aqueous phase (System 4 in Table 1). A low trehalose con-
centration was chosen because it represents the range of
concentrations reported in cryopreservation, lyophilization,
and other modeled membrane-trehalose studies (30,47–49).
To obtain a statistical analysis of the diffusion process, 10
sets of simulations were performed on each bilayer with and
without trehalose. We set up these simulations with a single
palmitate molecule in the aqueous phase because of aggre-
gation at higher concentrations (see Fig. S2 in the Supple-
mentary Material) and experimental evidence that shows the
free unbound palmitate in solution (;10 nM) are largely
responsible for the biophysical changes to the membrane
(50). Note that BSA, used in the experiments to prevent
palmitate aggregation, is not considered in the simulations.
Because palmitate is a relatively long molecule (in its fully
stretched, 16-carbon-long conformation), it was necessary to
consider systems with a large aqueous phase (40 waters per
lipid), so that the palmitate molecule would interact with only
one of the bilayer interfaces at any given time.
Experimental studies have shown that moderate to high
concentrations of palmitate induce signiﬁcant structural
changes to the bilayer, including membrane swelling (51),
membrane fusion (52,53), and degradation of membrane
integrity (52,54). To understand the effect of these phe-
nomena, two sets of simulations were proposed to explain the
global and local effect of palmitate on the membranes (see
Fig. S3 for pictorial representation). For the global effect,
NPT simulations were performed. Here the simulations
captured the effect of large membrane structures, because the
bilayer surface was allowed to adjust as palmitate molecules
were embedded into the bilayer. To avoid aggregation of
palmitate in the aqueous phase, the bilayer structures were
constructed to have various concentrations of palmitate em-
bedded into the bilayer before equilibration (Systems 5–8 in
Table 1). Simulations of these systems were used to address
the overall changes of the membrane structure in the presence
of palmitate. For the local effect, the changes in bilayer
structure are limited to a speciﬁc portion of the membrane
that is concentrated with palmitate. Here, NPzAT (constant
surface area) simulations were performed (surface area of the
bilayer constrained to that without palmitate). Similarly,
palmitate molecules were embedded in the bilayers before the
start of the simulations (Systems 9–12 in Table 1). The goal
of these latter studies was to investigate the membrane
swelling induced by palmitate, which may eventually lead to
membrane deformation or formation of ordered domains that
alter the membrane ﬂuidity.
The force-ﬁeld for POPC, POPE, and water are consistent
with those employed in previous studies (55–57), which in-
cludes intramolecular parameters for bonds, angles, proper
dihedral, and improper dihedral. The Ryckaert-Bellemans
potential was used for the torsion potential of the lipid hy-
drocarbon chains (58). Nonbonded interactions were de-
scribed by the parameters from Berger et al. (59–61) and
partial atomic charges were obtained from Chiu et al. (62).
The united-atom representation was used for the methyl/
methylene groups in the acyl chains of both POPC and
POPE. For POPE, the hydrogen atoms in the amine group are
explicitly listed in the topology. The optimized potential for
liquid simulations (OPLS-AA) force ﬁeld was used for tre-
halose (63). Palmitate was modeled in the protonated state
and described using parameters derived from the lipid force
ﬁeld. The carboxylic acid group was based on the parameters
of glutamic acid, which were available from the GROMOS
force ﬁeld (64). The single-point charge model was adopted
for water (65).
Simulations were performed at 310 K (see (66) for more
details on the parameters used in the simulations). A time-
step of 2 fs was used for all simulations. Coulombic and van
der Waal cutoff interactions were at 1.0 nm. Long-range
electrostatic interactions were corrected with the particle-
mesh Ewald method (67,68) (0.12 nm for the grid size,
TABLE 1 Composition for lipid bilayers
System Trehalose Palmitate Ensemble
1 — — NPT
2 30* — NPT
3 — 1* NPT
4 30* 1* NPT
5 — 16y NPT
6 — 32y NPT
7 — 48y NPT
8 — 64y NPT
9 — 16y NPzAT
z
10 — 32y NPzAT
z
11 — 48y NPzAT
z
12 — 64y NPzAT
z
All systems contain 144 lipids per leaﬂet with 40 waters per lipid. Each
leaﬂet contains an equal number of POPC and POPE.
*Molecules inserted in the aqueous phase.
yMolecules embedded in the bilayer.
zCompressibility set to zero in the x- and y-directions.
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fourth-order spline interpolation, and real-space cutoff at
1.0 nm). Periodic boundary conditions were applied in all
directions. Trajectories were collected every 2 ps. All simu-
lations were performed with the GROMACS 3.3.1 software
package (69,70) (single-precision mode) in parallel using
Virginia Tech’s System X (dual 2.3 GHz Apple Xserve G5)
(71).
EXPERIMENTAL RESULTS
Palmitate cytotoxicity and trehalose
protective role
We previously found that palmitate-induced toxicity led to
ROS production in HepG2 cells (12), but its effect was not
prevented upon treating with ROS scavengers. During oxi-
dative stress, yeast cells produce trehalose to protect them-
selves from damage by oxygen radicals (37). Therefore, we
evaluated the effect of trehalose on palmitate-induced tox-
icity in HepG2 cells. The level of cytotoxicity was measured
by the relative amount of LDH released in the medium. The
control consisted of HepG2 cells exposed to DMEMwith 4%
BSA. From Fig. 1, our measurements indicate that palmitate
signiﬁcantly increased the amount of LDH released, relative
to the control. As the concentration of trehalose increased, the
LDH released reduced signiﬁcantly. This protective effect
reached a maximum at a trehalose concentration of 0.13 mM,
whereupon further increase in the trehalose concentration
was detrimental to the HepG2 cells. Although the mechanism
of trehalose-induced toxicity is not a focus of this study, we
infer from previous studies, including our own, that trehalose
preferentially binds to the membrane and possibly causes
surface modiﬁcations that may affect cell activity (72–77).
As it will be demonstrated from our computational studies,
we found that trehalose can induce local hydrophobic/hy-
drophilic domains along the bilayer interface, a membrane
reorganization process whichmay have potentially detrimental
effects. Based on these ﬁndings, a trehalose concentration of
0.13 mM was optimum for alleviating the palmitate-induced
toxicity in HepG2 cells and it was used in all subsequent ex-
periments.
Trehalose on H2O2 release
We previously identiﬁed H2O2 as one of the ROS species
involved in the palmitate-induced toxicity of hepatoma cells.
To determine whether trehalose protected HepG2 cells by
scavenging H2O2, the measured H2O2 released into the me-
dium was normalized to total cellular protein. As shown in
Fig. 2, 48 h of palmitate exposure enhanced H2O2 release into
the medium, while trehalose signiﬁcantly reduced the H2O2
release in the presence of palmitate. The results suggest that
trehalose protects the cells in part by reducing H2O2 release.
Membrane ﬂuidity for HepG2 cells
Since palmitate is hydrophobic, there may be nonspeciﬁc
cytotoxic effects due to its hydrophobicity. It has been es-
tablished experimentally that trehalose has a stabilizing effect
on biological membranes (78), therefore we investigated the
changes in cellular membrane structure upon exposure to
palmitate in the presence and absence of trehalose. The cel-
lular membrane ﬂuidity of HepG2 cells in the presence of
palmitate or trehalose was measured by EPR. The EPR
spectra of the spin-label agents were used to detect changes in
the freedom of motion of the lipids in the cell membrane, thus
FIGURE 1 Effect of trehalose on the HepG2 cells cytotoxicity in response
to palmitate. Conﬂuent HepG2 cells in bovine serum albumin (BSA) me-
dium were exposed to 0.7 mM palmitate in the presence of different con-
centrations of trehalose. The LDH released was measured after 48 h. Open
and shaded bars represented the effect of trehalose alone or the mixtures of
trehalose/palmitate, respectively. Note that the ﬁrst shaded bar shows the
effect of palmitate alone. Error bars are standard deviation of three inde-
pendent experiments. The symbols * and # indicate statistical difference
from control and palmitate, respectively (p , 0.05).
FIGURE 2 Effects of trehalose and palmitate on H2O2 release. Conﬂuent
HepG2 cells in BSA medium were treated with 0.7 mM palmitate (Palm)
with or without 0.13 mM trehalose (Treh) for 48 h. The H2O2 released into
the medium was measured and normalized to total cellular protein. Error
bars are standard deviation of three independent experiments. The symbols *
and # indicate statistical difference from control and palmitate, respectively
(p , 0.05).
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providing a measure of the membrane ﬂuidity. The mem-
brane ﬂuidity of HepG2 cells were measured after 48 h of
exposure to palmitate, trehalose, and combinations thereof.
The control was HepG2 cells exposed to DMEM with 4%
BSA. Using 16-n-SASL as a probe to monitor the ordering of
the lipid tails near the center of the bilayer core, we observed
a greater peak height ratio for the palmitate-treated cells as
compared to the control, which correlated with reduced
freedom of motion of the spin labels in the membrane. This
indicates a decrease in membrane ﬂuidity of the cells treated
with palmitate for 48 h, as shown in Fig. 3 a. The exposure of
HepG2 cells to trehalose had an insigniﬁcant effect on the
bilayer core region since trehalose is excluded from the bi-
layer. The interaction of trehalose with the membrane is only
at the surface of the bilayer. Treating HepG2 cells with tre-
halose and palmitate increased the peak height ratio. This
suggests that a complex interaction exists between the cel-
lular membrane, palmitate, and trehalose. Similarly, using
5-n-SASL as a probe to monitor the lipid carbons near the
lipid headgroups, we observed that the presence of trehalose
in the palmitate-treated cells increased the ﬂuidity near the
surface of the membrane (see Fig. 3 b).
To corroborate the membrane ﬂuidity results, we measured
the phase transition temperature of DOPC liposomes by DSC
measurements. The DSC thermographs for DOPC liposomes
with varying mole fractions of palmitate (see Fig. 4) showed
that the phase transition temperature of the DOPC liposomes
increased with increasing concentration of palmitate. This
suggests that palmitate increase the ordering of the phospho-
lipids in the liposomes, which correlates with the decrease in
membrane ﬂuidity measured by EPR.
COMPUTATIONAL RESULTS
Based on the experimental results, exposure of healthy cells
to palmitate resulted in cytotoxicity, while the presence of
trehalose partially alleviated the negative effect by palmitate.
As such, there must be a complex interaction between pal-
mitate, trehalose, and the cell membrane to enable this pro-
cess to occur. Based on the large number of hydroxyl groups
present in trehalose, we hypothesize that the distribution of
hydrogen bonds among trehalose, phospholipid, and palmi-
tate is the key in determining the protective mechanism.
Therefore, MD simulations were performed on lipid bilayers
to elucidate the possible mechanisms of palmitate-induced
toxicity and the mechanism by which trehalose protects cells
from palmitate-induced toxicity. It should be noted that while
MD simulations to investigate the biological function of
trehalose (72–77) and palmitate (79,80), separately, are pres-
ent in the literature, their combined role is absent.
Palmitate dynamics
The initial stage of cell exposure to palmitate is modeled
by introducing a single palmitate molecule in the aqueous
phase of previously equilibrated bilayers with and without
FIGURE 3 Effect of palmitate exposure on cellular membrane ﬂuidity.
Cells were treated with 0.7 mM palmitate in the presence or absence of 0.13
mM trehalose for 48 h. The cellular membrane ﬂuidity was measured using
EPR. (a) Values are peak height ratio for 16-n-SASL-labeled HepG2 cells.
(b) Values are order parameter for 5-n-SASL-labeled HepG2 cells. Error
bars are standard deviation of four independent experiments. The symbols *
and # indicate statistical difference from control and palmitate, respectively
(p , 0.05).
FIGURE 4 Phase transition temperature of DOPC liposomes containing
palmitate. The phase transition was measured with DSC. Error bars are
standard deviation of three independent experiments. The symbol * indicates
statistical difference from control, 0% palmitate (p , 0.01).
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trehalose. Snapshots of the two systems at the start of the
simulation are shown in Fig. 5. To obtain a statistical sam-
pling of the palmitate penetration into the bilayer, 10 sets of
simulations were performed for each system with different
starting conﬁgurations and initial velocities. All simulations
lasted 40 ns regardless of the time when palmitate penetrated
the bilayer. Fig. 5, b and d, show representative trajectories of
palmitate along the simulation (trajectory is traced by the
position of the central carbon atom in the palmitate tail). As
seen in the ﬁgure, palmitate can penetrate the bilayer within
the simulation time considered. Eight of the ten simulations
resulted with palmitate in the bilayer and palmitate remained
in the aqueous phase for the duration of the simulations. For
the simulations with trehalose, similar results were obtained.
The observed penetration of palmitate in the bilayer is con-
sistent with experimental studies that demonstrated that pal-
mitate can be readily incorporate into the hydrophobic region
of the bilayer (81,82).
The following observations were made from the simula-
tions containing palmitate in the absence of trehalose. Ini-
tially in the aqueous phase, palmitate freely diffuses through
the water molecules. Due to the hydrophobic nature of pal-
mitate, entropic forces drive palmitate to migrate toward the
bilayer core region (hydrophobic environment). As palmitate
approaches the bilayer interface, numerous interactions must
occur before the hydroxyl group of palmitate (H-donor) can
favorably interact with the lipid oxygen atoms (H-acceptor)
through hydrogen bonding. Note that the lipid oxygen atoms
are those in the phosphate and carbonyl groups. First, at least
two hydrogen-bond pairs, one between water (H-donor) and
lipid oxygen atoms (H-acceptor), and another between the
palmitate hydroxyl group (H-donor) and water (H-acceptor)
must be broken for the palmitate to interact with the lipids, a
process that requires a substantial amount of energy. Second,
since the bilayer contains both POPC and POPE, an addi-
tional hydrogen bond between the amine groups of POPE
(H-donor) and neighboring lipid oxygen atoms (H-acceptor)
must be broken as well, if palmitate penetrates to the bilayer
near POPE. Finally, the hydrophobic nature of palmitate is
the driving force bringing palmitate closer to the bilayer in-
terface and eventually into the bilayer core; nevertheless, the
bilayer interface is hydrophilic and poses a barrier for pal-
mitate to penetrate into the bilayer core. For these reasons,
palmitate is often not readily incorporated into the bilayer
core as it approaches the interface. This is illustrated in the
trajectory shown in Fig. 5 b, where palmitate frequently in-
teracts with the lipid interface before penetrating the bilayer.
Once the alignment and interactions of palmitate at the in-
terface are favorable, palmitate penetrates the bilayer with the
hydrocarbon tail ﬁrst. This is also seen from Fig. 5 b, where
FIGURE 5 Starting structure of POPC/POPE
bilayer with one palmitate inserted into the aqueous
phase. Bilayers are modeled (a) without and (c)
with trehalose. Colored molecules are POPC/POPE
headgroup (blue), lipid tails (red), water (gray),
trehalose (green), and palmitate (cyan). See Table
1 for composition. The dynamics of palmitate, rep-
resented by the position of central carbon atom in
its tail, are shown in panels b and d. Blue horizontal
lines correspond to the average position of the phos-
phorus atoms of POPC and POPE along the inter-
face and are used to identify the interface. Gray
area denote the aqueous regions. The position z¼ 0
corresponds to middle of the aqueous phase.
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the palmitate trajectory remains almost stationary before
crossing the interface and then quickly moving into the bi-
layer core. For lipid bilayers containing trehalose, the inter-
actions of palmitate appeared to be much more complex, as
the exchange of hydrogen bonds among lipids, trehalose, and
palmitate have signiﬁcant affect on the dynamics of the
system.
Hydrogen-bond analysis
To investigate the protective role of trehalose on palmitate-
induced toxicity, we correlated the number of hydrogen
bonds between the bilayer lipids and palmitate up to the
penetration time. The H-donors consisted of the palmitate
hydroxyl group and the POPE amine group. The lipid and
palmitate oxygen atoms were the H-acceptors. A hydrogen
bond is deﬁned according to the criteria suggested by Brady
and Schmidt, with the distance between the donor and ac-
ceptor within 0.35 nm and the angle donor-hydrogen-
acceptor between 120 and 180 (83). The penetration time
is the time at which palmitate crosses the interface from the
aqueous phase into the bilayer. In the absence of trehalose,
palmitate penetrates the bilayer in shorter penetration time
and forms more hydrogen bonds with the lipids than in the
presence of trehalose. In the latter case, trehalose competes
with palmitate for hydrogen bonds with the lipids, and thus
trehalose can interfere with the interactions between the lip-
ids and palmitate. Therefore, longer penetration time and
fewer hydrogen bonds between the lipids and palmitate are
expected. From the 20 simulations considered (10 with and
10 without trehalose), 16 showed palmitate penetrating into
the bilayer within 40 ns of simulation. As shown in Fig. 6 a,
the data does not seem to correlate with the number of hy-
drogen bonds (lipid-palmitate) and the penetration time. This
suggests that the probability of palmitate penetrating the bi-
layer and interacting with the lipids and trehalose are more
complex than initially proposed.
Following a similar approach, we correlated the number of
hydrogen bonds between trehalose and palmitate up to the
penetration time to provide insight into how trehalose may
prevent palmitate-induced toxicity. Here, the H-donors and
H-acceptors consisted of trehalose and palmitate hydrogens
and oxygen atoms in the hydroxyl group, respectively. The
results, shown in Fig. 6 b, demonstrate a direct correlation
between the number of hydrogen bonds and the penetration
time, suggesting that trehalose may be directly interacting
with palmitate. Therefore, it is possible that, by interfering
with the interaction of palmitate with the bilayer lipids, tre-
halose reduces the probability of palmitate-inducing toxicity.
An extensive hydrogen-bond analysis was carried out to
investigate the interactions between lipids, trehalose, and
palmitate. Here, a correlation was made between the pene-
tration time and the number of hydrogen bonds present in the
system. From Fig. 6 b, shorter penetration time was observed
for systems with fewer hydrogen-bond interactions between
palmitate and trehalose. This suggests that, without trehalose,
palmitate should penetrate more quickly into the bilayer.
However, we see from the results that the penetration times
are about the same for the systems with and without treha-
lose. Since the penetration of palmitate is dependent upon the
lipid molecules exposed to the aqueous phase, we investi-
gated the bilayer interface to explain the results. Since the
bilayers consisted of two types of lipids, with POPE acting as
an H-donor, the intermolecular H-bond distribution between
lipids (the amine groups as H-donors and the lipid oxygen
atoms as H-acceptors) may provide insight into this incon-
sistency. To accomplish this task, we calculated the H-bond
distribution in the bilayer interface at the time of penetration.
Note that the interface is one to which palmitate penetrates
through. For clarity and discussion purposes, four bilayers
FIGURE 6 Correlation between the number of hydrogen bonds and pal-
mitate penetration time. Closed and opened circles shown in panel a are the
number of hydrogen bonds between lipid headgroups and palmitate for
bilayers without and with trehalose, respectively. Squares shown in panel b
are the number of hydrogen bonds between palmitate and trehalose.
Highlighted circular areas are the regions in which we speculate the results
to lie.
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without trehalose and four bilayers with trehalose were se-
lected. Fig. 7 shows the intermolecular hydrogen-bond dis-
tribution between lipids at the time of palmitate penetration.
The penetration time and location are indicated in the ﬁgure.
The ﬁrst observation from the plots is that palmitate pene-
trates the bilayer in regions with fewer H-bonds between
lipids. The void regions in the plots generally represent the
choline headgroup in POPC molecules exposed to the aque-
ous phase. Note that the choline groups have three methyl
groups, which are hydrophobic in nature. These facts and
observations led us to conclude that palmitate, a hydrophobic
molecule, prefers to penetrate the bilayer through hydrophobic
FIGURE 7 Snapshots of the hydrogen-bond distribution on a bilayer leaﬂet during the time of palmitate penetration for bilayers without (a–d) and with
trehalose (e–h) and over the course of simulations for bilayers without (i–l) and with trehalose (m–p). Circles represent the location of intermolecular hydrogen
bonds between the amine groups of POPE and neighboring lipid oxygen atoms. For bilayers considered with and without trehalose, the majority shows uniform
hydrogen-bond distributions (shaded circles in a–c and e–g). Inconsistent hydrogen-bond distributions are shown in dark shading (d and h). Over the course of
the simulation, the snapshots show uniform hydrogen-bond distributions for a bilayer without trehalose (i–l). Signiﬁcant changes in the distribution are
observed for bilayers with trehalose (m–p). Outlined square boxes are the approximate bilayer surface. The penetration time and location (*) are shown in each
ﬁgure.
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regions. Secondly, the H-bond distributions are more random
in systems without trehalose and become more localized in
systems with trehalose. As a result, there are fewer but large
hydrophobic regions exposed to the aqueous phase for sys-
tems containing trehalose, implying that trehalose has the
ability to modify the bilayer surface (84,85). Furthermore, the
penetration time varies depending on the palmitate location
and distribution of H-bonds on the surface. As seen in Fig. 7 d
for a system without trehalose, the H-bond distributions
are very similar to those systems containing trehalose (Fig. 7,
e–g); as a result, palmitate penetrates the bilayer with the
shortest amount of time. On the other hand, palmitate does
not penetrate the bilayer surface with large hydrophobic re-
gions, as shown in Fig. 7 h, mainly because palmitate inter-
acts with trehalose in the aqueous phase, thus preventing
palmitate from approaching the bilayer surface.
To verify that trehalose has the ability to modify the bilayer
surface, we monitored the intermolecular H-bond distribu-
tion between lipids over the course of the simulation. The
time considered for this analysis was between 5 and 15 ns.
Selected snapshots are shown in Fig. 7, i–p, for bilayers with
and without trehalose. It is evident from Fig. 7, i–l (system
without trehalose), that the H-bond distributions are random
throughout the bilayer surface, even at the time when pal-
mitate penetrates the bilayer. A different behavior is observed
for systems with trehalose, where signiﬁcant changes in the
H-bond distribution are observed before and after the pene-
tration time, as shown in Fig. 7, m–p. A shift in H-bond
distribution may have resulted from the multiple hydrogen
bonds between trehalose and lipid oxygen atoms, thus fa-
cilitating the local accumulation of polar regions on the bi-
layer interface (see Fig. S4 in Supplementary Material). This
demonstrates the dual role of trehalose: on the bilayer sur-
face, trehalose can alter the H-bond distribution, thus in-
ducing hydrophobic regions for palmitate to penetrate the
bilayer, while in the aqueous phase, trehalose can interact
with palmitate and prevent it from approaching the bilayer
surface. These two competing processes help us to under-
stand why the experimental measurements have shown that
trehalose at high concentrations (.0.13 mM) is detrimental
to HepG2 cells. At high trehalose concentrations, the bilayer
surface is signiﬁcantly modiﬁed by trehalose such that hy-
drophobic regions are more accessible for palmitate to pen-
etrate the bilayer.
Embedded palmitate in bilayers
Thus far, we have found that a palmitate molecule can pen-
etrate into the bilayer core within a short time (,40 ns).
Although systems with more than one palmitate were also
considered, their dynamics and properties contrast. This is
because hydrophobic/hydrophilic interactions between pal-
mitate molecules induce aggregation with characteristics
similar to micelles. The aggregation of palmitate molecules
in the aqueous phase partially shields the hydrophobic tails,
which in turn lessen the driving force for palmitate to pene-
trate the bilayer. Moreover, the time for a sufﬁcient number
of palmitate molecules to penetrate the bilayer would likely
require simulations into the microsecond domain. Therefore,
to overcome this limitation, we created several model bila-
yers with palmitate molecules embedded in the bilayer
structure (see Simulation Details). Since the amount of pal-
mitate varies depending on the cell type and the level of
toxicity, we considered a range of palmitate concentrations
(11–44 mol %; see Table 1 for more details). To be consistent
with previous analysis, the total number of lipids remained
the same.
The following sections describe the global effect of pal-
mitate embedded in the lipid bilayers (Systems 5–8 in Table
1). Since the bilayer surface was allowed to expand or con-
tract as palmitate molecules are added into the bilayer, a
correlation was established between the palmitate concen-
tration and the bilayer surface area. As shown in Fig. S5, the
total area per leaﬂet increases almost linearly with increasing
palmitate concentration. This is seen because palmitate oc-
cupies an additional volume within the bilayer and, due to its
alignment with the lipid tails, the bilayer expands in the lat-
eral dimensions. An approximate area per lipid and palmitate
can be determined using the criteria suggested by Edholm
and Nagle, which deals speciﬁcally with heterogeneous
systems (86). Although the bilayers considered here are
multicomponent systems (POPC, POPE, and palmitate), for
simpliﬁcation, the lipids are grouped as one component and
palmitate as the other. The area per molecule can be obtained
from
AtotalðxpalmitateÞ
Nlipid
¼ alipidðxpalmitateÞ1 xpalmitateð1 xpalmitateÞapalmitateðxpalmitateÞ;
(3)
where Atotal is the total area per leaﬂet; xpalmitate is the mole
fraction of palmitate in the bilayer; Nlipid is the total number
of lipids per leaﬂet; and alipid and apalmitate are the area
per lipid and area per palmitate, respectively. By plotting
Atotal(xpalmitate)/Nlipid versus xpalmitate/(1 – xpalmitate), as shown
in Fig. 8 a, alipid and apalmitate can be determined from the
y-intercept and slope, respectively. This analysis resulted in
an average area per lipid and area per palmitate of ;0.576
and 0.071 nm2, respectively. Our result for mixed 1:1 POPC/
POPE systems is in the range of the experimental area per
lipid for pure POPC (;0.64 nm2) and POPE (;0.56 nm2)
bilayers at 300 K (87,88).
To further investigate the global effect of palmitate inside
the membrane, a two-dimensional Voronoi tessellation anal-
ysis (89) was conducted on the equilibrium bilayer structure
for systems containing palmitate (Systems 1 and 5–8 in Table
1). For the analysis considered, the Voronoi plane was de-
ﬁned by the position of carbonyl carbon atoms of the lipid
and palmitate molecules, as these were located at about the
same depth in the bilayer. The result of a Voronoi tessellation
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analysis is a plot representing the spatial distribution of the
molecules in the bilayer (see the Supplementary Material for
a more detailed account of the Voronoi tessellation analysis
done). In particular, the Voronoi plots show a random and
disorder arrangement of the lipids and palmitate in the bi-
layer. Another useful property obtained fromVoronoi plots is
the area occupied by the lipid and palmitate molecules (cal-
culated from the area of the polygons), as shown in Fig. 8, b
and c, respectively. We see from the results in the ﬁgure that
the area per lipid decreases with increasing palmitate con-
centration, whereas the area per palmitate remains constant,
within statistical uncertainty. This demonstrates that palmi-
tate, a fatty acid molecule with a long hydrocarbon tail, is
laterally incompressible within the bilayer and its presence in
the bilayer decreases the void space between the lipid mol-
ecules, and consequently decreases the average area per lipid.
These observations are consistent with the reduced mem-
brane ﬂuidity (see Fig. 4) caused by the ordering induced by
palmitate in the bilayer. We should also note that the average
areas obtained from the Voronoi analysis differ from those
based on the Edholm and Nagle method (Fig. 8 a), with
exception of the pure bilayer where the estimate area per lipid
are ;0.576 and ;0.572 nm2, respectively. We believe the
Voronoi tessellation analysis provides a more reliable esti-
mate of the areas because it accounts for structural changes of
the molecules in the bilayer and it links the structure from the
simulations to the DSC measurements.
To investigate the local effect of palmitate embedded in the
membranes, the lateral expansion of the bilayers is con-
strained (see Simulation Details). This is intended to mimic
the local accumulation of palmitate in the bilayer. Fig. 9
demonstrates a signiﬁcant change in bilayer structure after 44
mol % of palmitate is embedded into the bilayer. Unlike the
global effect of palmitate embedded into the bilayer shown in
Fig. 9 b, straight lipid tails with tilted arrangements are ob-
served at higher palmitate concentrations (Fig. 9 c). This is
related to the ordered lipid phase, which has been shown to be
detrimental to cells by limiting their transport activities
(90,91), binding sites for pathogens and toxins (92–94), and
possibly the cause of palmitate-induced toxicity. As the
palmitate concentration decreases, the arrangement of the
FIGURE 8 (a) Average area per leaﬂet and palmitate concentration. Dashed
line is a linear regression of the data (ﬁtted equation and correlation coefﬁcient
are shown). Error bars are estimated standard deviation of the trajectories col-
lected over 50 ns. Plots b and c show the average area per lipid and palmitate
obtained from Voronoi tessellation analysis for the corresponding lipid
bilayers containing palmitate. Error bars are estimated standard error of the
mean area of Voronoi polygons (see Fig. S6 in Supplementary Material).
FIGURE 9 Snapshots of bilayer structures with (44 mol %) and without palmitate. (a) No palmitate is embedded in the bilayer. (b) The bilayer is allowed to
expand as more palmitate molecules are embedded in the bilayer. (c) The bilayer is constraint in the lateral directions as more palmitate molecules are
embedded in the bilayer. Dark gray molecules in the bilayer are palmitate. Compositions are described in Table 1.
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lipid tails become more random as observed in Fig. 9 a, thus
restoring the bilayer to its normal structure.
According to results shown in Fig. 8, it is implied that each
palmitate molecule occupies a speciﬁc volume within the
bilayer. This suggests that the structure of the lipid tails in the
vicinity of the palmitate molecules can be signiﬁcantly al-
tered. Fig. 10 shows the lipid tail order parameter for Systems
5–8. As seen in the ﬁgure, there is an increase in the order
parameter of the lipid tails as the palmitate concentration
increases. One reason for this behavior is the additional
volume occupied by the palmitate molecules, forcing the
surrounding lipid molecules to become highly packed, re-
sulting in a more ordered structure. Mechanistically, the area
per headgroup remains relatively the same, despite the pal-
mitate concentration; however, the area per lipid chain re-
duces signiﬁcantly because palmitate occupies the void
spaces that exist between the lipid chains. Since the lipid
chains become more ordered (gel state) at the current state, it
would require a higher temperature to transform them into a
more disorder state (liquid-crystalline state). Therefore, our
results demonstrated that the presence of palmitate increases
the phase transition temperature of mixed 1:1 POPC/POPE
bilayers.
Because the palmitate molecules are embedded in the bi-
layer at random, we are unable to quantify the local order
parameter near each palmitate molecule, and as such, an
average order parameter for the entire leaﬂet is reported. Note
that the aggregation of palmitate within the bilayer cannot be
captured within the timescale considered. However, the re-
sults do demonstrate swelling of the bilayers (see Fig. 9 b),
which may eventually cause the bilayer structure to rupture or
fuse with other cells, as reported by several experimental
studies (51–53). Fig. 9 shows the changes to the bilayer
structure caused by the addition of palmitate for the cases
where the bilayer freely expands and remains constrained as
palmitate is embedded in the bilayer (all bilayers contain the
same number of palmitate in each leaﬂet, a condition needed
to prevent distortion of the simulation box). As seen from the
structures, the increase in the ordering of the lipid tails is
related to the mixing of lipid and fatty acid components,
where straight chain fatty acid exhibits higher order param-
eters. Since the ordering of the lipid tails is directly related to
the phase transition, the simulation results agree well with the
DSC measurements for DOPC liposomes containing palmi-
tate, EPR measurements of HepG2 cells exposed to palmitate
(see previous section), and other related experiments (81,82),
all of which showed an increase in the phase-transition tem-
perature with increasing palmitate concentration. In com-
parison to the effect of cholesterol on membranes, another
predominant component in animal cells, our simulation re-
sults from the local and global effects of palmitate embedded
within the membranes agree well with previous simulations
of fully hydrated bilayers containing cholesterol, where in-
creasing ordering of the lipids in the membrane is observed
(95–98).
DISCUSSION
FFAs are known to play important roles in the development
of many hepatic disorders. A number of studies have shown
that elevated levels of fatty acids are important mediators of
lipotoxicity and can impair cellular functions and/or cause
cell death (99). Others have found that the negative effect of
FFA-induced toxicity may be reduced or alleviated by the
addition of unsaturated fatty acids, antioxidants, or, as of
more recently, disaccharides. To evaluate whether palmitate-
induced toxicity can be reduced by adding trehalose, we
exposed HepG2 cells to palmitate alone or a combination of
trehalose and palmitate. As demonstrated from our experi-
ment (Figs. 1 and 2), cells exposed to palmitate resulted in a
signiﬁcant amount of LDH and H2O2 released into the me-
dium, indicating cell death or compromised cellular mem-
brane. With increasing trehalose concentration, reduced
amount of LDH released is observed in the presence of pal-
mitate, up to ;13 mM, an optimal concentration for HepG2
cells. Furthermore, a signiﬁcant reduction in H2O2 released is
observed for these cells. To provide insight into the bio-
chemical and biophysical processes altered by the presence
of palmitate in HepG2 cells and to interpret these results from
a molecular level, we studied the effect of palmitate and
trehalose on model cell membranes (lipid bilayers) using
molecular dynamic simulations.
Based on the results obtained from the simulations, we
have demonstrated a potential mechanism by which palmi-
tate incorporates into the bilayer and the binding of trehalose
to palmitate through hydrogen bonding that may prevent
palmitate from reaching the cell membrane and being taken
FIGURE 10 Deuterium order parameter for (a) monounsaturated and (b)
saturated tails of POPC and POPE at 310 K. Lines correspond to: System
1 (solid), System 5 (dot), System 6 (dash), System 7 (dot-dash), and System
8 (dot-dot-dash).
Palmitate Toxicity 2879
Biophysical Journal 94(7) 2869–2883
up. The incorporation process of palmitate into the bilayer
may be similar to that in the detergent effect, where FFAs
solubilize membrane components and create holes in the
membrane. However, because the simulations are limited to
nanosecond timescale and the solubilization of the membrane
in the detergent effect process may occur in microseconds to
seconds, we are unable to determine at the present time
whether the detergent effect is actually the mechanism gov-
erning the toxicity by palmitate. Based on the results obtained
from previous studies, trehalose has been shown to bind
preferentially to the bilayer surface (72–74,77). This suggests
that the hydrogen bonding between trehalose (up to a certain
concentration) and the phospholipid components may prevent
the formation of pores, thus preserving the normal membrane
function and structure.
Modiﬁcation of the membrane lipid composition may alter
the membrane ﬂuidity and in turn affect cellular function
(100,101). As palmitate molecules are embedded within the
membrane, it is observed from the EPR measurements that
the membrane ﬂuidity is signiﬁcantly decreased (see Fig. 3).
This phenomenon can be explained by many factors. First,
palmitate is hydrophobic in nature and by exposing it to cell
membranes, palmitate is most likely dissolving into the
membrane, thus reducing the membrane ﬂuidity. Second, as
palmitate can be metabolized into phospholipid components
of cell membranes, these additional components can cause an
increase in the packing between the lipids, consequently
decreasing the membrane ﬂuidity (100,101). Last, since
H2O2 and *OH are present in cultured cells exposed to pal-
mitate, it has been reported that unsaturated phospholipids
are oxidized into fragment of saturated hydrocarbons with
various headgroup functionalities, some of which are highly
toxic to cells (102–105). Although, the oxidation of unsatu-
rated lipids generally results in an increase in ﬂuidity and
permeability of the membrane (106–109), the remaining
fragments inside the membrane, which are hydrophobic in
nature, can reduce the membrane ﬂuidity. In this study, we
found that palmitate decreased the cellular membrane ﬂuidity
of HepG2 cells. In support, a previous study found that pal-
mitate enrichment in HepG2 cells results in decreased
membrane ﬂuidity, as demonstrated by higher ﬂuorescence
polarization of 1,6-diphenyl-1,3,5-hexatriene (46). This was
expected, since others have shown that fatty acids incorpo-
rated into the membrane disrupted the bilayer structure and
changed the lipid phase-transition temperature (81,82). We
have observed similar results: increasing the concentration of
palmitate increases the phase-transition temperature of DOPC.
CONCLUSIONS
In this study, we performed a series of experimental and
computational measurements to gain insight into how tre-
halose interacts with HepG2 cells in the presence of palmi-
tate. Experimentally, we found that healthy HepG2 cells
exposed to palmitate resulted in a signiﬁcant amount of LDH
and H2O2 released into the medium, indicating cell death or
compromised cellular membrane. Furthermore, it is observed
from EPR measurements that the membrane ﬂuidity is sig-
niﬁcantly decreased in the presence of palmitate, especially
in the bilayer core region. The leading hypotheses for the
observed results are:
1. Palmitate dissolves into the membrane, thus reducing the
membrane ﬂuidity.
2. Palmitate metabolizes into phospholipid components of
cell membranes, thus increasing the packing between the
lipids.
3. The remaining fragments of oxidized lipids inside the mem-
brane (oxidized by H2O2 and *OH), which are hydrophobic
in nature, reduce the membrane ﬂuidity.
The computational component of this study is aimed
at interpreting and understanding the experimental results,
providing knowledge at the molecular level into the role of
palmitate and trehalose in the toxicity of HepG2 cells. As
illustrated by the results, the computation analyses conﬁrmed
that palmitate can dissolve into the bilayers within a short
time. As the palmitate concentration in the bilayer increased,
the order parameter of the lipid tails increased, which was
consistent with the experimental results showing reduced
membrane ﬂuidity. The ordering of the lipid tails was due to
the additional volume occupied by the palmitate molecules,
forcing the surrounding lipid molecules to become highly
packed, resulting in a more ordered structure. The local effect
of palmitate embedded in the bilayer was also considered.
The simulation results yielded a highly order bilayer structure
with the lipid tails in a tilted arrangement. These results
agreed well with DSC measurements for DOPC liposomes
containing palmitate and EPR measurements of HepG2 cells
exposed to palmitate. Furthermore, we veriﬁed that the direct
interactions of trehalose and palmitate in the medium through
hydrogen bonding potentially hinder palmitate from dis-
solving into the bilayer. The binding of palmitate to trehalose
seems beneﬁcial to cell membranes; however, we have also
discovered from our mixed bilayer model that trehalose can
potentially modify the bilayer surface by altering the surface
hydrogen-bond distribution, thus inducing hydrophobic re-
gions for palmitate to penetrate the bilayer.
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